Back
Xtrackers S&P 500 Scored & Screened ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
72
SNPE
Xtrackers S&P 500 Scored & Screened ETF
Last Price:
$62.12
Seasonality Move:
-2.65%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$55.85
Seasonality Move:
14.46%
Buy
72
Xtrackers S&P 500 Scored & Screened ETF (SNPE)
is a Buy
Is Xtrackers S&P 500 Scored & Screened ETF a Buy, Sell or Hold?
-
The current Xtrackers S&P 500 Scored & Screened ETF [SNPE] share price is $62.12. The Score for SNPE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
SNPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNPE Stock Price Chart
What is Xtrackers S&P 500 Scored & Screened ETF's stock price today?
-
The Xtrackers S&P 500 Scored & Screened ETF share price today is $62.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.86The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.
SNPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.62 | Buy |
| Relative Strength Index (14 RSI): | 54.51 | Buy |
| Chaikin Money Flow: | 349849 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.83 - 62.47) | Buy |
| Bollinger Bands (100): | (58.12 - 61.7) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 78181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.94 - 57.06) | Buy |
| Bollinger Bands (100): | (52.44 - 65.4) | Sell |
SNPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.08 | Buy |
| 20-day SMA: | 61.96 | Buy |
| 50-day SMA: | 61.32 | Buy |
| 200-day SMA: | 56 | Buy |
| 8-day EMA: | 32.72 | Buy |
| 20-day EMA: | 16.02 | Buy |
| 50-day EMA: | 6.98 | Buy |
| 200-day EMA: | 1.82 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.25 | Sell |
| 20-day SMA: | 55.05 | Buy |
| 50-day SMA: | 58.96 | Sell |
| 200-day SMA: | 51.1 | Buy |
| 8-day EMA: | 55.79 | Buy |
| 20-day EMA: | 55.79 | Buy |
| 50-day EMA: | 56.36 | Sell |
| 200-day EMA: | 37.56 | Buy |
Xtrackers S&P 500 Scored & Screened ETF Earnings Growth & SNPE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Xtrackers S&P 500 Scored & Screened ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||